RxDoctor Payments Data

Kara Mann, PA

Physician Assistant · Reading, PANPI 1578936118

Payments from drug & device makers

$1,784in general payments, 2019–2025

Across 95 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$408
  • Boehringer Ingelheim$282
  • Lilly USA, LLC$195
  • Pfizer$194
  • AbbVie$168
  • AstraZeneca$95
  • plus $442 from 9 others

What the payments were for

  • Food & beverage$1,784100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,784 in reported general payments places this provider in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$45,874
Medicare patients
141
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$54,520
MounjaroTirzepatide31$44,035
EliquisApixaban28$20,589
XareltoRivaroxaban11$14,462
LinzessLinaclotide16$11,592
Rosuvastatin Calcium139$2,658
Levothyroxine Sodium179$2,035
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,796
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,638
Atorvastatin Calcium183$1,445
Omeprazole88$1,215
Losartan Potassium142$1,173
Amlodipine Besylate206$1,117
Gabapentin62$1,043
Metoprolol Succinate79$986

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$408$54,52050 claims
Lilly USA, LLCMounjaro$195$44,03531 claims
PfizerEliquis$194$20,58928 claims
AbbVieLinzess$168$11,59216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →